<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="90855">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02088853</url>
  </required_header>
  <id_info>
    <org_study_id>BUTTER</org_study_id>
    <nct_id>NCT02088853</nct_id>
  </id_info>
  <brief_title>Diet Induced Intestinal Mucosal Adaptation</brief_title>
  <official_title>Small Intestinal Adaptation to Isocaloric Diets Dominated Either by Fats or Carbohydrates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Göteborg University</source>
  <oversight_info>
    <authority>Sweden: Central Ethical Review Board, Stockholm, Sweden</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Human beings are 'omnivores' meaning that all principal components of food (i.e. the
      macronutrients: carbohydrates, fat, proteins) can be assimilated by the gastrointestinal
      tract. When the gut mucosa is exposed to dietary changes it adjusts its functional
      behaviour. For example, a fatty diet demands certain digestive mechanisms, whereas others
      are needed to take care of a carbohydrate rich diet. Such dietary induced changes in
      appearance and functionality of the small intestinal mucosa have been described in animals
      but only little is known about it in man. The present project aims at elucidating in man if
      a 2 weeks diet dominated by either fat or carbohydrates, but with similar energy content, is
      associated with changes in the small intestinal mucosal appearance and metabolic signalling
      capacity.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Mucosal surface enlargement factor</measure>
    <time_frame>Appearance after 2 weeks of diet</time_frame>
    <safety_issue>No</safety_issue>
    <description>The enlargement of the luminal surface area due to the villi structure is a morphometric factor defined as the total area of the mucosal surface in relation to the relatively flat area of the muscular is mucosae.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Epithelial electrical current in-vitro</measure>
    <time_frame>The condition after 2 weeks diet</time_frame>
    <safety_issue>No</safety_issue>
    <description>Mucosal biopsies are mounted in minUssing chambers. Ion-transporting capacity via SGLT-1 transported is reflected when switching from glucose-free to glucose-containing luminal solution, selectivity of transporter is confirmed by addition of phloridzin.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mucosal electrical resistance in vitro</measure>
    <time_frame>The condition after 2 weeks diet</time_frame>
    <safety_issue>No</safety_issue>
    <description>Mucosal biopsies are mounted in miniUssing chambers. Electrical resistance reflecting paracellular permeability is assessed when switching from glucose-free to glucose-containing luminal solution.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemic control following a test meal</measure>
    <time_frame>The condition after 2 weeks diet</time_frame>
    <safety_issue>No</safety_issue>
    <description>Blood concentrations of glucose and insulin are assessed over 2 hours following a mixed test meal.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Healthy Conditions</condition>
  <arm_group>
    <arm_group_label>high fat diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>high carb diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>high fat diet (hfd)</intervention_name>
    <description>Sixty % of the energy content is based on fat.</description>
    <arm_group_label>high fat diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>high carb diet</intervention_name>
    <description>Sixty % of the energy content is based on carbohydrates.</description>
    <arm_group_label>high carb diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        healthy volunteer not taking prescribed medications BMI ≤25 kg/m2

        Exclusion Criteria:

        BMI ≥26 kg/m2 smoker previous or current gastrointestinal disease significant abdominal
        surgery pregnancy/breast feeding drug intolerance of importance (particularly opiates and
        midazolam used during endoscopy) history of drug addiction
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Fändriks, MD, PhD, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Göteborg University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lars Fändriks, MD, PhD</last_name>
    <phone>+46313424123</phone>
    <email>lars.fandriks@gastro.gu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Niclas Björnfot, RN</last_name>
    <phone>+46313428404</phone>
    <email>gastlab.su@vgregion.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept of Gastrosurgical R&amp;E, Sahlgrenska Universityhospital</name>
      <address>
        <city>Gothenburg</city>
        <zip>SE41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Fändriks, MD, PhD</last_name>
      <phone>+46313424123</phone>
    </contact>
    <investigator>
      <last_name>Lars Fändriks, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 14, 2014</lastchanged_date>
  <firstreceived_date>March 13, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Göteborg University</investigator_affiliation>
    <investigator_full_name>Prof Lars Fandriks</investigator_full_name>
    <investigator_title>Professor, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>intestinal</keyword>
  <keyword>metabolic control</keyword>
  <keyword>mucosa</keyword>
  <keyword>human</keyword>
  <keyword>diet</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
